...
首页> 外文期刊>Anticancer Research: International Journal of Cancer Research and Treatment >Polyphosphoester-based Paclitaxel Complexes: Biological Evaluation
【24h】

Polyphosphoester-based Paclitaxel Complexes: Biological Evaluation

机译:基于多磷酸酯的紫杉醇配合物:生物学评估

获取原文
获取原文并翻译 | 示例

摘要

Background: Polymer drug delivery systems designed to reduce systemic side-effects are clinically important. Polyphosphoesters are biodegradable polymers with versatile structure that could afford reactive sites or polar functions for drug immobilization. Materials and Methods: The drug-polyphosphester systems were characterized by nuclear magnetic resonance and infrared spectroscopy, differential scanning calorimetry and dynamic light scattering. In vitro and in vivo experiments were performed to assess the biological activity of the immobilized drug. Results: Two water-soluble polyphosphoester-based delivery systems of paclitaxel were synthesized. The conjugate with paclitaxel covalently bonded to the polymer, had attenuated activity in vitro. The second system comprised of macromolecular aggregates incorporating the drug via hydrogen bonding. The physical complex achieved a certain level of antitumor activity in vivo and no decrease of body weight - evidence for reduction of the systemic toxic effect associated with paclitaxel treatment. Conclusion: The physical complex was found to be a promising carrier for delivery of toxic anticancer agents, e.g. paclitaxel.
机译:背景:旨在减少全身性副作用的聚合物药物递送系统在临床上很重要。聚磷酸酯是具有通用结构的可生物降解的聚合物,可以为药物固定提供反应位点或极性功能。材料与方法:用核磁共振和红外光谱,差示扫描量热法和动态光散射对药物-聚磷酸酯体系进行了表征。进行体外和体内实验以评估固定化药物的生物学活性。结果:合成了两种水溶性的基于聚磷酸酯的紫杉醇递送系统。紫杉醇与聚合物共价结合的结合物在体外具有减弱的活性。第二种系统由通过氢键结合药物的高分子聚集体组成。该物理复合物在体内达到了一定水平的抗肿瘤活性,并且体重没有降低-这是与紫杉醇治疗相关的全身毒性作用降低的证据。结论:发现该物理复合物是用于递送有毒抗癌剂的有前途的载体,例如。紫杉醇。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号